Named on one round in the feed.
Since 2026-09-15
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Evvy Evvy sells an at-home vaginal microbiome test and a clinical care platform that treats the conditions it finds. | Series B Verified against 1 of 14 sources | $40M | 2026-09-15 | [ PART ] |